ESSA Pharma Inc.

NASDAQ: EPIX · Real-Time Price · USD
1.93
0.01 (0.52%)
At close: Aug 15, 2025, 3:59 PM
1.93
0.00%
Pre-market: Aug 18, 2025, 05:04 AM EDT

ESSA Pharma Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Net Income
-28.54M -26.58M -35.1M -36.81M
Depreciation & Amortization
90.68K 118.49K 121.79K 109.46K
Stock-Based Compensation
6.54M 5.01M 7.89K 9.48K
Other Working Capital
-418.81K 2.47M -1.26M -721.15K
Other Non-Cash Items
-293.46K -664.48K -830.78K -35.29K
Deferred Income Tax
n/a n/a n/a -107.02K
Change in Working Capital
-418.81K 2.34M -780.01K 1.95M
Operating Cash Flow
-22.72M -19.78M -28.7M -25.42M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-39.23M -365.2M -296.01M -57.03M
Sales Maturities Of Investments
131.02M 361.68M 242.96M 22.01M
Other Investing Acitivies
n/a n/a 705.02K -35.01K
Investing Cash Flow
91.79M -3.53M -52.35M -35.01M
Debt Repayment
n/a -136.87K -134.02K -100.28K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
925.51K 68.71K 386.76K -7.91M
Financial Cash Flow
925.51K -68.16K 252.74K 141.99M
Net Cash Flow
70.01M -23.37M -80.75M 81.5M
Free Cash Flow
-22.72M -19.78M -28.7M -25.42M